Literature DB >> 29165569

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal.

Teresa Amato1, Abibatou Sall2, Tandakha NDiaye Dièye3, Alessandro Gozzetti4, Michele Iacono5, Maria Raffaella Ambrosio1, Massimo Granai1, Serena Somma4, Saliou Diop2, Awa Oumar Touré2, Evelyne May6, Charles Henry Gattiollat6, Joëlle Wiels6, Yonis Ahmed7, Martine Raphael6, Lorenzo Leoncini1, Cristiana Bellan1, Pier Paolo Piccaluga8,9.   

Abstract

OBJECTIVES: Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western populations, being rarer in Asian and African people. It has been suggested that patients with CLL from Africa might have a more aggressive disease compared with white patients. In this study, we aimed to identify genetic factors that may account for this difference.
METHODS: We analyzed immunoglobulin heavy chain (IGH) genes' mutational status by performing next-generation sequencing in 25 Senegalese and 50 Italian patients with CLL.
RESULTS: We found that Senegalese patients more frequently had adverse prognostic factors and an unmutated profile. Furthermore, we documented that IGHV1 (IGHV1-69), IGHD3, and IGHJ6 were significantly more frequent in Senegalese patients, whereas IGHV3-30 was common and limited to the Italian cohort. Stereotyped receptors commonly detected in the white population were not recorded in our Senegalese series.
CONCLUSIONS: The different IGH repertoire we observed in the Senegalese cohort may reflect the diverse genetic and microenvironmental (ie, polymicrobial stimulation) background. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Chronic lymphocytic leukemia; Immunoglobulin heavy chain genes rearrangements; Immunoglobulin heavy chain variable region genes

Mesh:

Substances:

Year:  2017        PMID: 29165569     DOI: 10.1093/ajcp/aqx105

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Response to Comment by Amato T. et al.

Authors:  Ilaria Del Giudice; Robin Foà
Journal:  Haematologica       Date:  2019-11       Impact factor: 9.941

2.  IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221).

Authors:  Teresa Amato; Massimo Granai; Lorenzo Leoncini; Cristiana Bellan
Journal:  Haematologica       Date:  2019-10       Impact factor: 9.941

3.  IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.

Authors:  Massimo Granai; Teresa Amato; Arianna Di Napoli; Raffaella Santi; Federica Vergoni; Gioia Di Stefano; Virginia Mancini; Sofya Kovalchuk; Emanuele Cencini; Alberto Giulio Carta; Sara Aversa; Marita Ziepert; Gabriele Cevenini; Stefano Lazzi; Lorenzo Leoncini; Cristiana Bellan
Journal:  Virchows Arch       Date:  2019-12-04       Impact factor: 4.064

4.  Smudge cells percentage on blood smear is a reliable prognostic marker in chronic lymphocytic leukemia.

Authors:  Abibatou Sall; Moussa Seck; Seynabou Fall; Fatimata Bintou Sall; Blaise Félix Faye; Fatou Samba Ndiaye; Macoura Gadji; Saliou Diop; Awa Oumar Touré; Martine Raphaël
Journal:  Hematol Transfus Cell Ther       Date:  2021-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.